These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review. Leroux E; Buchanan A; Lombard L; Loo LS; Bridge D; Rousseau B; Hopwood N; Matthews BR; Reuter U Adv Ther; 2020 Dec; 37(12):4765-4796. PubMed ID: 32990921 [TBL] [Abstract][Full Text] [Related]
23. Triptans: over the migraine. Cologno D; Mazzeo A; Lecce B; Mundi C; Petretta V; Casucci G; d'Onofrio F Neurol Sci; 2012 May; 33 Suppl 1():S193-8. PubMed ID: 22644202 [TBL] [Abstract][Full Text] [Related]
24. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine. McCormack PL; Foster RH Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021 [TBL] [Abstract][Full Text] [Related]
25. [Clinical use of triptans in the management of migraine]. Lantéri-Minet M CNS Drugs; 2006; 20 Spec no.1():12-23. PubMed ID: 16841523 [TBL] [Abstract][Full Text] [Related]
26. Triptans for migraine management in adolescents. Winner P Headache; 2002; 42(7):675-9. PubMed ID: 12482222 [TBL] [Abstract][Full Text] [Related]
27. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694 [TBL] [Abstract][Full Text] [Related]
28. Increasing the effect of triptans in migraine. Tfelt-Hansen P; Olesen J Lancet; 2006 Oct; 368(9544):1313-4. PubMed ID: 17046449 [No Abstract] [Full Text] [Related]
29. Almotriptan: an effective and well-tolerated treatment for migraine pain. Pascual J Drugs Today (Barc); 2003; 39 Suppl D():31-6. PubMed ID: 15071618 [TBL] [Abstract][Full Text] [Related]
30. Current perspectives on effective migraine treatments: are small clinical differences important for patients? Ferrari MD Drugs Today (Barc); 2003; 39 Suppl D():37-41. PubMed ID: 15071619 [TBL] [Abstract][Full Text] [Related]
31. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Ferrari MD; Roon KI; Lipton RB; Goadsby PJ Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541 [TBL] [Abstract][Full Text] [Related]
32. An economic evaluation of triptan products for migraine. Perfetto EM; Weis KA; Mullins CD; Subedi P; Healey PJ Value Health; 2005; 8(6):647-55. PubMed ID: 16283865 [TBL] [Abstract][Full Text] [Related]
33. Comparison chart of triptans. Med Lett Drugs Ther; 2017 Feb; 59(1514):e27-e29. PubMed ID: 28170367 [No Abstract] [Full Text] [Related]
34. Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan. Díez FI; Straube A; Zanchin G J Neurol; 2007 Feb; 254(2):242-9. PubMed ID: 17334957 [TBL] [Abstract][Full Text] [Related]
35. The triptan formulations : how to match patients and products. Rapoport AM; Tepper SJ; Bigal ME; Sheftell FD CNS Drugs; 2003; 17(6):431-47. PubMed ID: 12697002 [TBL] [Abstract][Full Text] [Related]
39. Eletriptan: a review of its use in the acute treatment of migraine. McCormack PL; Keating GM Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799 [TBL] [Abstract][Full Text] [Related]
40. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Tfelt-Hansen P; De Vries P; Saxena PR Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]